Now I have all the information I need. Let me compile the final review.

## Calibration Summary

**Round 1 — Bracketing:**
- Weak anchors (<3.5): V83xzYnZ5q (3.0), CpiOUOaqh3 (2.0) — weak epidemiological papers, rejected
- Middle anchors (3.5-7.5): DL7JWbdGr3 — PEMs (4.75, Reject) — *closest topical match, same problem of cross-disease epidemic pre-training; reviewers cited insufficient baselines, hard to disentangle pre-training from architecture*
- Strong anchors (>7.5): PdaPky8MUn (8.0), agPpmEgf8C (8.0) — clearly stronger, accepted papers

**Round 1 bracket:** Between 3.5 and 5.5 (below PEMs at 4.75 due to more directly contradictory ablation evidence)

**Round 2 — Narrowing:**
- DL7JWbdGr3 — PEMs (4.75): Topically closest anchor. The PEMs paper proposed SSL pre-training across multiple epidemic datasets. It was rejected with concerns about insufficient baselines, difficulty disentangling pre-training from architecture, and limited novelty. HG-DCM has a stronger architecture story (deep compartmental model) and interpretability features, but its ablation evidence is actually weaker — T-DCM (no history) directly contradicts the paper's core narrative on mean MAE. HG-DCM is slightly below PEMs in evidence quality.
- QMkYEau02q — PhyDL-NWP (4.25): Physics-guided weather forecasting. Rejected with concerns about limited improvements over baselines. Similar pattern: good idea, mixed evidence.
- sSWiZr8QU7 (4.00): Hybrid gray-box model simulation. Rejected.
- 3X6QlkWfHH (4.00): Gray-box modeling for pain/opioid. Rejected.

**Final score:** 4.0 — below PEMs (4.75) because the paper's own ablation data (Table 2, mean MAE) directly undermines the central narrative that "historical data is the primary driver," a problem more severe than what PEMs reviewers flagged. The paper has a good idea, solid architecture, and useful dataset, but the experimental evidence is insufficient to support the claimed contribution.

---

## Summary

HG-DCM introduces a deep compartmental model that transfers knowledge from multiple past pandemics (Ebola, SARS, Dengue, seasonal influenza) to stabilize early-stage COVID-19 forecasting. The core idea — using a neural network to predict the parameters of a compartmental model (DELPHI) by learning from historical outbreaks — is well-motivated and timely. On 258 global locations, HG-DCM substantially reduces median MAE and overshoot events compared to the standard DELPHI model. However, the paper's central claim that historical data is the "primary driver" of improvement is undermined by its own ablation results, the head-to-head comparison against external baselines is limited to two locations, and key aspects of the evidence are mixed.

## Strengths

- **First systematic cross-disease temporal transfer for cold-start pandemic forecasting.** The paper's novelty is well-articulated: prior work transfers across space (from one region to another) or across related epidemics, but not across biologically distinct pandemics using a unified deep compartmental framework. The paper explicitly claims this distinction and backs it up with a concrete architecture.

- **Substantial improvements over the standard DELPHI compartmental model on median MAE across 258 locations.** With 2 weeks of training data, HG-DCM reduces median MAE by 38.2% relative to DELPHI; with 4 weeks, 32.4% (Table 2). Both mean and median MAE favor HG-DCM over DELPHI at all training windows, often by an order of magnitude.

- **Quantitative reduction in catastrophic overshoot events.** Figure 4a shows that HG-DCM produces markedly fewer overshooting predictions than DELPHI across all training window lengths. The overshoot metric (predicted cumulative cases >5× observed) is a practically meaningful indicator of model stability.

- **Interpretable parameter inference with epidemiological meaning.** The framework preserves the interpretability of compartmental models: predicted parameters (infection rate, timing of interventions, death rate) can be inspected and compared. Figure 5 shows tighter parameter distributions for HG-DCM vs. DELPHI.

- **Novel data augmentation strategies for pandemic time series.** Window-shift augmentation (past pandemics) and block-masking augmentation (current pandemic) are specifically designed for the unique data constraints of pandemics, avoiding look-ahead bias.

- **Construction of a new comprehensive multi-pandemic dataset.** The paper compiles case/death data, epidemiological metadata, and country-level indicators for major outbreaks since 1990 (COVID-19, Ebola, SARS, Dengue, seasonal influenza). This is a reusable resource.

## Weaknesses

### Major

- **Ablation results partially contradict the central narrative that "historical data is the primary driver."** T-DCM — which removes all historical data and metadata while keeping the same neural architecture — achieves *lower mean MAE* than HG-DCM at 2 weeks (15,049 vs. 18,603) and *dramatically lower* at 4 weeks (17,691 vs. 110,452). The 4-week gap is an order of magnitude. The paper acknowledges this only implicitly (by reporting both mean and median) and never explains it. The Discussion's claim that "the primary driver of this success is not the complexity of the neural network, but the strategic integration of historical data" is not supported by these numbers. While HG-DCM consistently beats T-DCM on *median* MAE, the mean MAE tells the opposite story. A method that fails catastrophically on enough locations to inflate its mean 62× above its median at 4 weeks (110,452 mean vs. 1,771 median) is not "consistently" outperforming. The paper must (a) characterize which locations fail and why, (b) explain the mean–median divergence, and (c) revise the Discussion claims accordingly.

- **Head-to-head comparison against external baselines (GradABM, EiNNs) is limited to two locations (US, Massachusetts).** The paper is transparent about this — "These locations were selected because they were the only locations in which there was available data and code for the comparison methods" — but the claimed superiority over these methods nonetheless rests on a 2-location case study. The ablation infrastructure runs on 258 locations (Table 2), so the limitation is a baseline-availability issue, not a paper design flaw per se, but it severely limits the generality of the claims against non-DELPHI methods.

- **Overshoot analysis does not support the historical-data narrative.** Figure 4a shows HG-DCM and CNN (a pure deep learning baseline with *no* historical data) have *similar* overshoot counts — both are lower than DELPHI. This suggests the deep learning backbone, not the historical data, is mainly responsible for reducing overshoot. The paper attributes the overshoot reduction to "leveraging historical pandemic information," but the ablation data do not distinguish between the DL architecture effect and the historical-data effect.

### Minor

- **MAE on raw cumulative case counts is poorly suited for cross-location aggregation.** Case counts vary by orders of magnitude across locations, so a single catastrophic failure on a large-population location can dominate the mean. The 62× ratio between mean and median MAE for HG-DCM at 4 weeks is a red flag. The paper's loss function already uses MAPE (weighted by α), so reporting per-capita or percentage errors (e.g., MAE per 100,000 or sMAPE) would naturally complement the raw MAE. The paper reports both mean and median, which is good practice, but draws conclusions primarily from the median without addressing the mean discrepancy.

- **The parameter inference analysis (Section 3.2.3) is suggestive but not evidential.** The Wilcoxon test merely shows the two models produce different parameters, which is trivial given different architectures and training data. The paper claims HG-DCM's parameters are "more robust and consistent" and "avoid overfitting," but there is no ground truth for the parameters. A more meaningful validation would correlate the parameters with known epidemiological characteristics, interventions, or outcomes.

- **The loss function incorporates an unremarked asymmetry.** The past-pandemic loss (Eq. 3) includes the forecasting window (length t+v), while the current-pandemic loss (Eq. 4) includes only the training window (length t). This means the model is supervised on the future trajectory of historical pandemics but not on the current one. While practically necessary (the current pandemic's future is unknown), this asymmetry could encourage reliance on forecasting-window patterns in historical data that may not transfer. A brief discussion would address this.

### Trivial

- The description of seasonal influenza data (2009–2023) in the dataset section could benefit from a note on how its dynamics (preexisting immunity, annual seasonality) differ from novel pandemics — the paper already acknowledges this implicitly but should be explicit.

## Nice-to-Haves

- **Zero-shot forecasting** (training only on historical data, no current-outbreak data at all). The paper tests 2–8 weeks of current data. Zero-shot would be the most impactful real-world scenario (a truly novel pathogen with zero observations) and would directly test whether historical transfer alone provides useful signal.
- **Pre-training + fine-tuning baseline** (e.g., pre-train on historical data alone, then fine-tune on current-outbreak data). This would isolate the historical-data effect from the architecture effect more cleanly than the current T-DCM comparison.
- **Per-location failure analysis** characterizing which pandemic types or locations cause the mean MAE blowup at 4 weeks.

## Removed Points

*Weaknesses from the harsh critic moved here with justifications:*

- **"No prior research has integrated information across a wide range of different pandemics" is overstated.** *Removed per rules: this is a related-work completeness concern, and the paper cites relevant prior work (Tindale et al., Roster et al., Panagopoulos et al.). The novelty claim is about *systematic cross-disease temporal transfer* which is distinct from spatial transfer or borrowing single-outbreak priors.*
- **Missing appendix sections (code, reproducibility details).** *Removed per hard rules: the appendix is stripped by the parser, the original submission contains these sections.*
- **Request for zero-shot or missing reproducibility details.** *Moved to Nice-to-Haves; not a core flaw.*
- **Seasonal influenza should be ablated out of training.** *Moved to Nice-to-Haves; a reasonable suggestion for strengthening, not a current weakness.*
- **Loss of format/typo/grammar issues.** *Removed per hard rules: parser artifacts.*
- **Criticism that results are "not significant" without statistical tests on forecasting accuracy.** *The paper reports point estimates on 258 locations; reporting confidence intervals on all ablation conditions would strengthen the paper but demanding this as a fatal flaw is not appropriate for this community's standards. Moved to Minor.*

## Novel Insights

None beyond the paper's own contributions. The harsh critic raises a genuinely insightful tension (mean vs. median MAE in the ablation) that the paper itself does not address — this is the most important gap and represents the main barrier to accepting the paper's narrative.

## Suggestions

1. **Directly address the mean–median MAE discrepancy in Table 2.** Identify which locations cause the mean MAE blowup at 4 weeks for HG-DCM. Are these specific pandemic types, countries, or data regimes? This analysis is essential for understanding when the method works and when it fails.

2. **Revise the Discussion claim that "the primary driver... is the strategic integration of historical data."** The evidence does not support this categorical statement. Instead, characterize the relative contributions of the deep learning architecture vs. historical data more cautiously, noting that the DL backbone independently contributes to overshoot reduction and that T-DCM without history achieves competitive mean MAE at short horizons.

3. **Add per-capita or relative error metrics** (e.g., MAE/100k population, sMAPE) to the main ablation table. This would clarify whether the mean MAE advantage of T-DCM at 2–4 weeks is an artifact of location size disparities.

4. **Report the overshoot counts for T-DCM** alongside HG-DCM, CNN, and DELPHI in Figure 4a. This would directly test whether the overshoot reduction is due to the architecture or the historical data.

## Score and Decision

Based on the calibration analysis: the paper is below the PEMs anchor (4.75, Reject) because its own ablation data creates a stronger contradiction with its central claim than the issues that led to PEMs' rejection. The paper's idea is worthwhile, and the architecture is sensible, but the evidence as presented does not support the claimed conclusions. With a revised discussion, mean-median analysis, and additional metrics, this could become a stronger submission.

**Round 1 bracket:** (3.5, 5.5)  
**Round 2 anchors read:** DL7JWbdGr3 (PEMs, 4.75, Reject) — similar cross-disease epidemic pre-training but cleaner evidence; QMkYEau02q (4.25, Reject) — similar pattern of good idea, mixed evidence; sSWiZr8QU7 (4.00, Reject); 3X6QlkWfHH (4.00, Reject).

**Final position:** Slightly below PEMs (4.75) — comparable approach quality with weaker experimental support for the central narrative. Score anchored to the 4.0 range.

MY FINAL SCORE: <score>4.0</score>
MY FINAL DECISION: <decision>Reject</decision>